Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Isolation of arylhalodiphosphenes: periodic trends in R–P[double bond, length as m-dash]P–X bonding (X = Cl, Br, I)

John S. Wenger*a, Nina Gaschikb, William J. Rowea, Agamemnon E. Crumptona, Bono van IJzendoorna and Meera Mehta*a
aDepartment of Chemistry, University of Oxford, 12 Mansfield Road, Oxford, OX1 3QR, UK. E-mail: john.wenger@chem.ox.ac.uk; meera.mehta@chem.ox.ac.uk
bDepartment of Chemistry, Ludwig-Maximilians-Universität München, Butenandtstrasse 5-13, 81377 München, Germany

Received 26th January 2026 , Accepted 18th February 2026

First published on 25th February 2026


Abstract

For over a century, aryldiazonium halides have served as widely used building blocks within synthetic chemistry. They are vital intermediates in converting simple anilines to high-value products, including those needed to prepare pharmaceuticals, dyes, and functional materials. Despite the prevalence of these nitrogen-based organic salts in laboratories, structurally related phosphorus-based salts remain scarce. Herein, we report the isolation and structural characterization of a monomeric arylchlorodiphosphene, (MsFluInd*)P[double bond, length as m-dash]PCl·(Et2O)2 (where MsFluInd* is a sterically demanding hydrindacene substituent), for the first time. The structure and reactivity of (MsFluInd*)P[double bond, length as m-dash]PCl were explored to compare the novel arylhalodiphosphene with compositionally related aryldiazonium chlorides, [RNN][Cl], and chloroiminophosphanes, RN[double bond, length as m-dash]PCl. The P–P bond of (MsFluInd*)P[double bond, length as m-dash]PCl was cleaved via protonolysis to afford the parent phosphine, (MsFluInd*)PH2. Halogen-exchange reactions between (MsFluInd*)P[double bond, length as m-dash]PCl and TMSX (TMS = trimethylsilyl, X = Br, I) afforded the related monomeric arylhalodiphosphenes, (MsFluInd*)P[double bond, length as m-dash]PX (X = Br, I). Finally, the coordination complex, [(MsFluInd*)P[double bond, length as m-dash]PCl·Ag][CF3SO3], was isolated by treatment of (MsFluInd*)P[double bond, length as m-dash]PCl with AgCF3SO3. Periodic trends in the structure and bonding of (MsFluInd*)P[double bond, length as m-dash]PX (X = Cl, Br, I) were investigated with spectroscopic, crystallographic, and computational methods. These studies confirm that the {PPX} moeity consists of a formal P–P double bond, and polar covalent P–X (X = Cl, Br, I) single bonds. (MsFluInd*)P[double bond, length as m-dash]PX (X = Cl, Br, I) represent the first fully characterized, crystalline arylhalodiphosphenes and serve to advance the state of low-coordinate phosphorus chemistry.


Introduction

The isolation of heavy element analogues of common organic functional groups remains central to advancing our understanding of periodic trends and developing new precursors.1,2 The inherent challenges in stabilizing molecular species bearing multiple bonds between main-group elements heavier than those of the second period of the periodic table is encapsulated by the so-called “double bond rule”.3–5 Such molecules often form self-associated oligomers rather than retaining the heavy element–element multiple bond.6 Chemists may overcome this challenge by invoking thermodynamic stabilization whereby a Lewis acid and/or base is used to perturb the frontier molecular orbitals of the reactive unsaturated fragment,7 and/or via kinetic stabilization where the reactive fragment is sterically protected.8,9

Initially reported in 1858, aryldiazonium chlorides are conveniently prepared by treatment of anilines with HCl and NaNO2 (Fig. 1).10 Aryldiazonium salts have served as important reagents and intermediates in numerous key named reactions, including the Sandmeyer reaction,11 Pschorr reaction,12 Gomberg–Bachmann reaction,13 Balz–Schiemann reaction,14 and Meerwein arylations.15 These reagents continue to be under intense investigation for their powerful utility in converting simple anilines to value-added products via diverse synthetic pathways.16 Despite the prevalence of diazonium salts across synthetic chemistry, analogous species in which one or both of the diazonium N atoms are replaced by a heavier pnictogen remains rare. In an early report, (Mes*)N[double bond, length as m-dash]PCl (Mes* = 2,4,6-tri-tert-butylphenyl) was isolated by treating the corresponding aniline with an excess of PCl3 and Et3N (Fig. 1).17 (Mes*)N[double bond, length as m-dash]PCl may be viewed as a “monophosphadiazonium chloride” in which the Cl atom directly binds the terminal P atom, in contrast to diazonium chlorides which do not feature a similar N–Cl bond and instead exist as separated ion pairs even in the solid-state.18 Coordination of the Cl anion to the terminal P-atom disrupts multiple-bonding between the N and P atoms, and (Mes*)N[double bond, length as m-dash]PCl features an N–P double bond. (Mes*)N[double bond, length as m-dash]PCl may undergo halogen-exchange reactions to form (Mes*)N[double bond, length as m-dash]PX (X = Br, I) by treating (Mes*)N[double bond, length as m-dash]PCl with the corresponding trimethylsilyl (TMS) halide (Fig. 1).


image file: d6sc00723f-f1.tif
Fig. 1 General synthesis of [RNN][Cl] (i = excess HCl, excess NaNO2). Synthesis of (Mes*)NPCl and [ClP(µ-PMes*)]2 (ii = excess PCl3, excess Et3N). Synthesis of [(Mes*)NP][AlCl4] (iii = AlCl3). Synthesis of (Mes*)NPX (iv = TMSX; X = Br, I). Depiction of (MsFluInd*)PPX (X = Cl, Br, I) reported herein. Structural diagrams of ligands MsFluInd* and Mes*.

(Mes*)N[double bond, length as m-dash]PCl has served as a seminal precursor to phosphadiazonium compounds. For example, treatment of (Mes*)N[double bond, length as m-dash]PCl with AlCl3 resulted in chloride abstraction to form the iminophosphenium tetrachloroaluminate, [(Mes*)NP][AlCl4] (Fig. 1). The same group later isolated a range of oxy-substituted iminophosphanes by treatment of (Mes*)N[double bond, length as m-dash]PCl with silver or lithium salts.19 Further, iminophosphenium species may also be generated in situ by reacting with GaCl3.20 Recently, the chloroiminophosphane, (Ter*)N[double bond, length as m-dash]PCl [Ter* = bis(ortho-m-hexaisopropylterphenyl)phenyl] was prepared from the bulky aniline (Ter*)NH2 and employed as a precursor in the isolation of a two-coordinate phosphindene oxide, (Ter*)NBnPO.21 Further, (MsFluInd*)N[double bond, length as m-dash]PCl was recently prepared from (MsFluInd*)NH2 and served as a precursor for an aryliminophosphinyl radical, (MsFluInd*)NP.22

Numerous diphosphenes of the form RP[double bond, length as m-dash]PR’ have been reported since the seminal discovery of the diaryldiphosphene, (Mes*)P[double bond, length as m-dash]P(Mes*).23 The stability of diphosphenes is largely attributed to the presence of bulky substituents at each P atom that form a sterically protected cavity for the P–P double-bonded core to reside.24 Compounds featuring {P2} fragments stabilized by either carbene ligands or transition metals have also been isolated.25–30

Asymmetric diphosphenes that feature an alkyl, alkoxy, or amino group in addition to an aryl substituent have also been reported and, in some cases, have served as precursors to donor-stabilized diphosphadiazonium species.31–34 Treatment of the aminoaryldiphosphenes, (Mes*)P[double bond, length as m-dash]PNR2 (NR2 = N(iPr)2, N(cyclohexyl)2, or 2,2,6,6-tetramethylpiperidine) with one equivalent of HCF3SO3 affords ammonium salts, [(Mes*)P[double bond, length as m-dash]PNHR2][CF3SO3], which are stable in solution at −50 °C.35 Remarkably, treatment of a 1[thin space (1/6-em)]:[thin space (1/6-em)]1 mixture of (Mes*)P[double bond, length as m-dash]PNR2 and Ph3P with two equivalents of HCF3SO3 affords [(Mes*)P[double bond, length as m-dash]P(PPh3)][CF3SO3], which was initially reported as a donor-stabilized diphosphadiazonium cation. However, crystallographic and computational data indicate that [(Mes*)P[double bond, length as m-dash]P(PPh3)][CF3SO3] is best described as a diphosphene with an adjacent triphenylphosphonium center.36

Treatment of (Mes*)P[double bond, length as m-dash]PNiPr2 with HCl was reported to form monomeric (Mes*)P[double bond, length as m-dash]PCl via the loss of HNiPr2.37 However, (Mes*)P[double bond, length as m-dash]PCl was reported to exist only transiently at −50 °C in solution, and its structure has only been inferred by 31P NMR analysis and follow-on reactivity studies with organolithium reagents to form asymmetric diphosphenes.38 Monomeric (Mes*)P[double bond, length as m-dash]PX (X = Br, I) were reported to be prepared by treatment of (Mes*)P[double bond, length as m-dash]PNiPr2 with HX (X = Br, I), or by treatment of [(Mes*)P[double bond, length as m-dash]P(PPh3)][CF3SO3] with [Et3NH][X] (X = Br, I) at −78 °C, but again these compounds were only characterized by 31P NMR spectroscopy and it is unclear at which temperature these spectra were collected.35,39 The existence of monomeric (Mes*)P[double bond, length as m-dash]PX (X = Cl, Br, I) as isolable reagents has recently been called into question in the absence of conclusive analytical evidence and crystallographic characterization; treatment of the primary phosphine, (Mes*)PH2 with an excess of PCl3 and NEt3, does not afford monomeric (Mes*)P[double bond, length as m-dash]PCl, but rather affords the dimeric form [ClP(µ-PMes*)]2, which was characterized in both solution and solid-state (Fig. 1).36,40,41

Herein, we report the isolation of a crystalline, monomeric arylchlorodiphosphene, (MsFluInd*)P[double bond, length as m-dash]PCl (8) (Fig. 1). Spectroscopic, crystallographic, and computational characterization of compound 8 confirms the presence of a formal P–P double bond and a polar, covalent P–Cl single bond, in contrast to compositionally analogous aryldiazonium chlorides of the form [RNN][Cl]. The terminal {PPCl} unit in 8 is kinetically stabilized by the sterically demanding hydrindacene substituent, MsFluInd*.42 The unsaturated P–P bond in 8 may be cleaved via protonolysis to form the primary phosphine, (MsFluInd*)PH2 (4). Treatment of compound 8 with TMSBr or TMSI affords (MsFluInd*)PPBr (9), and (MsFluInd*)PPI (10), respectively, highlighting the synthetic utility of the terminal P–Cl bond in 8. Attempts to abstract the Cl atom from 8 with AlCl3 or GaCl3 afforded complex reaction mixtures, while treatment of 8 with AgCF3SO3 afforded the coordination complex, [(MsFluInd*)PPCl·Ag][CF3SO3] (11). Periodic trends in structure and bonding between the novel catalogue of isolable arylhalodiphosphenes 8, 9, and 10 were explored with spectroscopic, crystallographic, and computational methods.

Results and discussion

Synthesis of novel phosphine precursors

Inspired by the success of bulky hydrindacene-based ligands in stabilizing reactive molecular fragments,22,42–59 literature known (MsFluInd*)Br (1) was treated with an excess of tert-butyl lithium to form (MsFluInd*)Li (2) in situ,42 which was subsequently treated with PCl3 to afford (MsFluInd*)PCl2 (3), characterized as the hexane solvate (Scheme 1). Compound 3 was then reduced with an excess of LiAlH4 to afford (MsFluInd*)PH2 (4) (Scheme 1). However, we found it was most efficient to synthesize 4 directly from 1 without fully isolating 3. Like other primary phosphines bearing bulky aryl substituents, 4 is air-stable in both the solid-state and in solution.60,61 Compound 4 could be crystallized from a −30 °C solution of hexane to afford colorless blocks of 4·(hexane). Structural characterization of 4·(hexane) by single-crystal X-ray diffraction (SC-XRD) confirms the presence of a terminal {PH2} group within the sterically protected environment created by the flanking fluorenyl substituents of the MsFluInd* ligand (Fig. 2A).
image file: d6sc00723f-s1.tif
Scheme 1 Synthesis of compounds 2, 3, and 4.

image file: d6sc00723f-f2.tif
Fig. 2 Thermal ellipsoid plot (50% probability) of (A) 4·(hexane), (B) 5·(toluene)2.5, (C) 6·(Et2O)2, and (D) 7·(Et2O)2. Solvent molecules, C-bound H atoms, and disordered components are omitted for clarity. Only the major component of disorder is displayed in all cases. Select C atoms and H atoms are shown as spheres of arbitrary radius for clarity. Color code: P orange, Cl dark green, Si dark yellow, K sky blue, C black, H grey.

Compound 4·(hexane) was reacted with potassium benzylate (KBz) in benzene to form intensely red solutions of (MsFluInd*)PHK (5) in situ (Scheme 2), which was structurally characterized as a toluene solvate (Fig. 2B). In the solid-state, 5·(toluene)2.5 exists as a centrosymmetric dimer in which a disordered toluene molecule resides on the crystallographic inversion center and coordinates the potassium ions. Each potassium ion is further coordinated by a 6-membered ring within the fluorenyl groups and by the anionic P-donor.


image file: d6sc00723f-s2.tif
Scheme 2 Synthesis of compounds 5, 6, 7, and 8.

We hypothesized that a silylated phosphine substituted with the sterically demanding MsFluInd* substituent could serve as an effective precursor for the synthesis of unsaturated main-group species. (MsFluInd*)PTMSH (6) was isolated via sequential treatment of 4·(hexane) with KBz followed by TMSCl (Scheme 2). Colorless blocks of analytically pure 6·(Et2O)2 were isolated by crystallization from Et2O solutions at −30 °C. 6·(Et2O)2 crystallizes in the P[4 with combining macron]21m space-group on a special position distinguished by a two-fold rotation axis and two mirror planes, such that 0.25 of the MsFluInd* ligand resides in the asymmetric unit and the central {PTMSH} unit is disordered about these symmetry elements (Fig. 2C).

Sequential treatment of 4·(hexane) with KBz followed by PCl3 successfully afforded (MsFluInd*)PHPCl2 (7) which was obtained as the Et2O disolvate from solutions of 7 in Et2O at −30 °C (Scheme 2). The 31P{1H} nuclear magnetic resonance (NMR) spectrum of 7·(Et2O)2 exhibits a prominent pair of doublets at −41 ppm and 209 ppm with a 1JPP value of 247 Hz, consistent with the presence of a P–P single bond in 7.62 Additionally, the 31P and 1H NMR spectra confirm a P-bound proton in 7 with 1JPH = 219 Hz and 2JPH = 14.5 Hz. Crystals of 7·(Et2O)2 are crystallographically isomorphic with 6·(Et2O)2 and feature a terminal {PHPCl2} motif disordered about multiple positions (Fig. 2D). Unfortunately, we were unable to isolate 7·(Et2O)2 as an analytically pure material; we attribute our inability to purify 7 to the high crystallinity and similar solubility of MsFluInd*-containing impurities, a common challenge associated with the use of such sterically demanding substituents.21,42,63

Synthesis and reactivity of a monomeric arylchlorodiphosphene

Treatment of a hexane solution of 7·(Et2O)2 with triethylamine resulted in the formation of a yellow suspension (Scheme 2). Removal of the solid by-product [Et3NH][Cl] and volatiles, followed by recrystallization of the residue from Et2O resulted in the isolation of yellow crystals. Analysis of the crystalline product by 31P NMR spectroscopy revealed two new doublets in the spectrum, which do not exhibit any 1H coupling (Fig. 3A). The 31P NMR resonances of the product are shifted strongly downfield with respect to the precursor at 433 ppm and 502 ppm and exhibit a larger 1JPP coupling constant of 574 Hz, consistent with an asymmetric diphosphene species with a P–P double bond.31,36,64–66 Furthermore, the infrared (IR) spectrum of the product features a strong band assigned to the P–Cl stretch that appears at a lower wavenumber (νP–Cl = 451 cm−1) relative to that of 7·(Et2O)2 (νP–Cl = 461 cm−1) (Fig. 3B, SI Fig. S34).
image file: d6sc00723f-f3.tif
Fig. 3 Stacked (A) 31P NMR spectra and (B) IR spectra of 8·(Et2O)2, 9·(Et2O)2, and 10·(Et2O)2. Signals in the IR spectrum assigned to a P–X bond stretching mode are denoted with an asterisk.

Analysis of the yellow crystals by SC-XRD reveals the sample to be crystallographically isomorphic with those of 6·(Et2O)2 and 7·(Et2O)2; the product also crystallizes in the P[4 with combining macron]21m space group with nearly identical unit cell parameters. However, solution of the solid-state structure confirms a distinct Fourier difference map within the cavity created by the MsFluInd* ligand. Indeed, the crystallographic data are fit excellently by 8·(Et2O)2 (R1 = 4.62%). Our model features disorder between a major E-isomer with an occupancy of 85% (Fig. 4A) and a minor Z-isomer with an occupancy of 15% with respect to the asymmetric diphosphene unit. The major E-isomer is further disordered about two positions, and the entire {PPCl} motif is disordered about a special position. We note that the connectivity of 8·(Et2O)2 is unambiguous, but meaningful discussion of structural parameters is precluded by this disorder. Remarkably, compound 8 may also be synthesized by treatment of 6·(Et2O)2 with KBz followed by PCl3 via the formal elimination of KCl and TMSCl (Scheme 2).


image file: d6sc00723f-f4.tif
Fig. 4 Thermal ellipsoid plots (50% probability) depicting the major E-isomer for (A) 8·(Et2O)2, (B) 9·(Et2O)2, (C) 10·(Et2O)2, and (D) 11. The refined E[thin space (1/6-em)]:[thin space (1/6-em)]Z occupancy ratios in our models are 85[thin space (1/6-em)]:[thin space (1/6-em)]15, 78[thin space (1/6-em)]:[thin space (1/6-em)]22, 60[thin space (1/6-em)]:[thin space (1/6-em)]40, and 67[thin space (1/6-em)]:[thin space (1/6-em)]33 for 8·(Et2O)2, 9·(Et2O)2, 10·(Et2O)2, and 11, respectively. Only the major component of disorder for the E-isomer of 8·(Et2O)2 and 9·(Et2O)2 are depicted. Solvent molecules, H atoms, and disordered components are omitted for clarity. Select C atoms are shown as spheres of arbitrary radius for clarity. Color code: P orange, Cl dark green, Br blue, I purple, Ag navy, F pink, S yellow, O red, C black.

For most monomeric diphosphenes, the synthesis of Z-isomers from E-isomers requires photolytic conditions and low temperatures, and warming solutions of the resulting Z-isomer to room-temperature results in the formation of the more stable E-isomer.31,67,68 The observed isomerism in the solid-state structure may be the result of a photoisomerization reaction during the diffraction experiment.69 The apparent isomerism identified in our diffraction study prompted us to perform variable-temperature NMR (VT NMR) studies. The 31P NMR resonances for 8 do indeed broaden at low temperature; however, it is unclear if there is dynamic exchange between the E- and Z-isomers in solution. Notably, the sterically encumbered arylhydrazinodiphosphene, RP[double bond, length as m-dash]PMes* (R = (Me3Si)2N(SiMe3)N) can be isolated as either the E or Z isomer, and isomerizes at room temperature in solution to an equilibrium E[thin space (1/6-em)]:[thin space (1/6-em)]Z ratio of 11[thin space (1/6-em)]:[thin space (1/6-em)]6.70

Aryldiazonium halides are well known to form either phenols or aryl bromides in the presence of aqueous hydrobromic acid, via loss of the terminal {N2} unit.16 In contrast, treatment of a solution of 8·(Et2O)2 in C6D6 with an excess of concentrated hydrobromic acid in water results in the formation of compound 4 via protonolysis of the P–P bond (Scheme 3). Unfortunately, we were unable to characterize the by-product from this protonolysis.


image file: d6sc00723f-s3.tif
Scheme 3 Reactivity of 8: Protonolysis of 8 to form 4. Synthesis of 9 and 10. Treatment of 8 with AlCl3 or GaCl3. Synthesis of 11.

(Mes*)N[double bond, length as m-dash]PCl was reported to engage in rapid halogen-exchange reactions in the presence of TMSBr or TMSI at 0 °C.17 Whilst compound 8 does not undergo similar reactions at 0 °C or room-temperature, heating toluene solutions of 8 in the presence of excess TMSBr or TMSI for 16 h at 100 °C results in the formation of 9 and 10, respectively (Scheme 3). The 31P NMR spectrum of 9 exhibits a characteristic pair of doublets at 490 and 445 ppm with a 1JPP value of 567 Hz (Fig. 3A). Similarly, 31P NMR analysis of 10 reveals a pair of doublets at 474 and 457 ppm with a 1JPP value of 554 Hz (Fig. 3A). With these values in hand, we note that the 1JPP coupling constant decreases from 8 > 9 > 10, consistent with a systematic weakening of the P–P bond as the terminal halide increases in size. Further, the pair of doublets appears with a lower difference in chemical shift to each other from 8 > 9 > 10. The lower difference in chemical shift is consistent with a reduced polarity of the P–X bond (X = Cl, Br, I) as the X substituent becomes less electronegative from 8 > 9 > 10. Combustion analyses of compounds 8·(Et2O)2, 9·(Et2O)2, and 10·(Et2O)2 are consistent with expected elemental compositions; however, 31P{1H} NMR data for each of these species reveal the presence of trace impurities which could not be removed by recrystallization.

Comparison of the IR spectra of 8, 9, and 10 finds the expected decrease in wavenumber for the P–X stretch as the X atom becomes heavier (Fig. 3B). The P–Br stretch appears at 367 cm−1, while the P–I stretch is not observed in the spectral window. The fingerprint regions of 8, 9, and 10 are, essentially, indistinguishable.

Compounds 9·(Et2O)2 and 10·(Et2O)2 were each crystallized from Et2O at −30 °C and exhibit similar crystallographic isomorphism to 6·(Et2O)2, 7·(Et2O)2, and 8·(Et2O)2. The solid-state structures determined by SC-XRD for 9 and 10 each feature disorder between a major E-isomer and a minor Z-isomer (Fig. 4B and C).

After demonstrating the halogen-exchange reactivity of 8·(Et2O)2, we explored halogen-abstraction reagents in an effort to replace the Cl substituent with a weakly coordinating anion (Scheme 3). Heating solutions of 8·(Et2O)2 in toluene to 100 °C for 16 h in the presence of either TMS(CF3SO3), AlCl3, or GaCl3 resulted in incomplete conversion of 8 to a complex mixture of products (SI Fig. S71). However, if compound 8 is isolated in the absence of Et2O then reaction with AlCl3 or GaCl3 proceeds at room temperature, again to form a complex mixture of products (SI Fig. S72). We hypothesize that Cl-abstraction occurs in these reactions, followed by rapid decomposition of a transient diphosphadiazonium cation. Efforts to capture or detect this transient diphosphadiazonium cation are currently ongoing.

The iminophosphenium triflate, [(Mes*)NP][CF3SO3], may be prepared via treatment of (Mes*)N[double bond, length as m-dash]PCl with AgCF3SO3, through the elimination of insoluble AgCl.19 In contrast, treatment of 8·(Et2O)2 with AgCF3SO3 under similar conditions affords the coordination complex 11, confirmed by SC-XRD studies (Scheme 3). The 31P{1H} NMR spectrum of 11 features a pair of broadened resonances at 463 and 351 ppm, consistent with interaction of the Ag ion with the diphosphene motif.71,72 Compound 8 is found to coordinate Ag+ in an η1-κ(P) mode that is commonly observed in coordination complexes involving diphosphenes, with the internal C-bound P atom coordinating to Ag+ (Fig. 4D).31 Remarkably, the solid-state structure of 11 features a two-component disorder arising from the presence of the E and the Z isomer of the coordinated diphosphene, 8, in a 68[thin space (1/6-em)]:[thin space (1/6-em)]32 occupancy ratio, respectively. These results ultimately highlight the divergent reactivity between the chloroiminophosphane, (Mes*)N[double bond, length as m-dash]PCl, and compound 8.

Theoretical analysis of monomeric arylhalodiphosphenes

Curious to investigate periodic trends in structure and bonding amongst this newly discovered class of monomeric arylhalodiphosphenes, the theoretical molecules E-8*, E-9*, E-10*, Z-8*, Z-9*, and Z-10* (pictured in the SI Fig. S73–S75) were optimized at the PBE0-D3/def2-TZVPP level of theory. Selected bond metrics are provided in SI Tables S5 and S6.

Frequency calculations predict the enthalpy of formation of E-8* to be 2.96 kcal mol−1 more favorable than that of Z-8*. Similarly, E-9* and E-10* are predicted to be more stable than Z-9* and Z-10* by 3.48 kcal mol−1 and 3.83 kcal mol−1, respectively. Calculated gas-phase 31P NMR spectroscopic data (PBE0-D4/pcsseg-2//PBE0-D3/def2-TZVPP) found the 1JPP coupling constant for E-8* to be more consistent with our experimental value than that calculated for Z-8* (SI Table S21). Subsequent discussions are limited to the more stable theoretical E-isomers. The P–X bond stretching frequencies for E-8*, E-9*, and E-10* were calculated to be 481, 392, and 357 cm−1. The associated P–X stretching force constants are 2.10, 1.73, and 1.45 mdyne/Å, respectively, showing the weakening of the P–X bond from E-8* > E-9* > E-10*. The P–P bond stretching frequencies for E-8*, E-9*, and E-10* are 656, 653, and 649 cm−1 and predicted to have negligible intensity.

A single point energy calculation at the DKH-PBE0/old-DKH-TZVPP level of theory was performed on the optimized coordinates of E-8*, E-9*, and E-10* for a detailed computational analysis (SI Tables S10–S17), and the summarized results are discussed. Topological analysis of the electron density (ρ)73 of E-8*, E-9*, and E-10* along the P–P interatomic vector reveals bond critical points, at which ρ = 0.156, 0.155, and 0.154 e Bohr−3, respectively (Fig. 5A). The negative Laplacian of ρ (∇2ρ) in the P–P valence region signifies significant charge concentration and covalency of the dipnictene bond of E-8*, E-9*, and E-10* (Fig. 5B).74 We also calculate significant ellipticity of ρ (ε) in the P–P valence region, consistent with formal double bond character of the interaction (Fig. 5C). Along the P–X (X = Cl, Br, I) interatomic vector, ρ = 0.120, 0.106, and 0.090 e Bohr−3 at the bond critical point for E-8*, E-9*, and E-10*, respectively, reflecting the weakening of the P–X bond from E-8* > E-9* > E-10* (Fig. 5D). The 2ρ function in the P–Cl bonding region in E-8* is highly asymmetric and signifies a polarization of charge towards the more electronegative Cl atom, reflecting the ionic character of the bond (Fig. 5E). For E-9* and E-10*, the ∇2ρ function in the P–X (Br, I) bonding region is dramatically less polarized (Fig. 5E). Topological analysis along the P–C bond path in E-8*, E-9*, and E-10* is reminiscent of that of the P–Cl bond in E-8*, but features higher values of ρ at the bond critical point, and values of the ∇2ρ function in the bonding region are less polarized and more negative, consistent with a stronger, more covalent bonding interaction (Fig. 5G and H). Values for ε along the P–X (X = Cl, Br, I) and P–C bond paths in E-8*, E-9*, and E-10* are low, but not negligible and likely signify π-type donor–acceptor interactions (Fig. 5F and I).


image file: d6sc00723f-f5.tif
Fig. 5 Values of (A) ρ (e Bohr−3), (B) ∇2ρ (e Bohr−5), and (C) ε for E-8*, E-9*, and E-10* along the P–P interatomic vector, with the C-bound P atom at 0.00 and the X-bound P atom (X = Cl, Br, I) at 1.00 along the horizontal axis. Values of (D) ρ (e Bohr−3), (E) ∇2ρ (e Bohr−5), and (F) ε for E-8*, E-9*, and E-10* along the P–X (X = Cl, Br, I) interatomic vector. Values of (G) ρ (e Bohr−3), (H) ∇2ρ (e Bohr−5), and (I) ε for E-8*, E-9*, and E-10* along the P–C interatomic vector. The bond lengths are normalized to 1.00. The location of the (3, −1) critical point is shown with a dashed vertical line. Calculations were performed at the (DKH-PBE0/old-DKH-TZVPP//PBE0-D3/TZVPP) level of theory.

The highest occupied molecular orbital (HOMO) of E-8* is highly delocalized and largely comprised of contribution by the P–P π bond and a Cl-centered lone pair (Fig. 6A). The lowest unoccupied molecular orbital (LUMO) of E-8* is largely defined by P–P π* contribution and the LUMO+2 of E-8* is largely defined by P–Cl σ* contribution (Fig. 6B and C). Similar results were obtained for E-9* and E-10*; however, the LUMO+1 is largely comprised of the P–X σ* (X = Br, I) contribution in these cases (SI Fig. S77–S82).


image file: d6sc00723f-f6.tif
Fig. 6 (A) HOMO, (B) LUMO, and (C) LUMO+2 of E-8* (isovalue = 0.015). Surface plots (isovalue = 0.06) for E-8*, depicting the (D) P–P π bonding NLMO, (E) P–P π* antibonding NLMO, (F) P–Cl σ* antibonding NLMO, (G) a Cl-centered lone pair, (H) overlap between a Cl-centered lone pair and the P–P π* antibonding NLMO, and (I) overlap between the P–C σ bonding NLMO and the P–Cl σ* antibonding NLMO. In Fig. 6A–H, the molecule is viewed down the plane defined by the {PPCl} unit. In Fig. 6I, the molecule is oriented differently for clarity of the displayed NLMOs. Color code: P orange, Cl dark green, C black, H grey. Displayed NLMOs are pre-orthogonalized. Calculations were performed at the (DKH-PBE0/old-DKH-TZVPP//PBE0-D3/TZVPP) level of theory.

Energetic analysis of the canonical molecular orbitals (CMO) reveals the HOMO increases in energy from E-8* < E-9* < E-10* while the LUMO and LUMO+1 decrease in energy from E-8* > E-9* > E-10* (Fig. 7). These data are consistent with the weakening of the P–P and P–X (X = Cl, Br, I) bonds as the terminal halide becomes heavier. We performed a similar energetic analysis of the simple, theoretical diaryldiphosphene, E-MesP[double bond, length as m-dash]PMes (E-12*), for comparison, and E-12* features a significantly lower LUMO than the theoretical arylhalodiphosphenes (Fig. 7).


image file: d6sc00723f-f7.tif
Fig. 7 Calculated orbital energies (DKH-PBE0/old-DKH-TZVPP//PBE0/def2-TZVPP) for E-8*, E-9*, E-10*, and E-12* with frontier molecular orbitals shown in color. The upper panel contains the values for the LUMO, LUMO+1, LUMO+2, LUMO+3, and LUMO+4. The lower panel contains values for the HOMO, HOMO–1, HOMO–2, HOMO–3, and HOMO–4.

Experimental ultraviolet-visible (UV-Vis) spectra of 8·(Et2O)2, 9·(Et2O)2, and 10·(Et2O)2 feature λmax values of 349 nm, 355 nm, and 370 nm, respectively, reflecting the lowering of the LUMO from E-8* > E-9* > E-10*. Time-dependent density functional theory (TD-DFT) calculations suggest that the observed yellow color in these species is predicted to arise from electronic transitions between the HOMO–3/HOMO–2/HOMO–1/HOMO and the LUMO in each case (SI Tables S12–S14).

Natural Population Analysis (NPA) reveals a systematic decrease in negative charge on the halide from E-8* > E-9* > E-10* (SI Fig. S84). Similarly, a decrease in positive charge is calculated for the X-bound P atom from E-8* > E-9* > E-10*. These results are consistent with a less polarized P–X bond as the halide increases in size. The theoretical asymmetric diphosphenes, E-MesP[double bond, length as m-dash]P(tBu) (E-13*), E-MesP[double bond, length as m-dash]P(SiMe3) (E-14*), E-MesP[double bond, length as m-dash]P(OMe) (E-15*), E-MesP[double bond, length as m-dash]P(NMe2) (E-16*), [E-MesP[double bond, length as m-dash]P(NMe3)]+ (E-17*), and [E-MesP[double bond, length as m-dash]P(PMe3)]+ (E-18*) were investigated at the same level of theory to compare polarization of the P–P bond in arylhalodiphosphenes with other asymmetric diphosphenes (pictured in the SI Fig. S83). NPA analysis suggests that among the arylhalodiphosphenes, the P–P bond becomes increasingly polarized from E-8* < E-9* < E-10*, as the positive charge on the X-bound (X = Cl, Br, I) P atom decreases. The alkyl-substituted diphosphene, E-13* features a relatively unpolarized P–P bond, similar to E-8* and E-9*. However, the heteroatom-substituted aryldiphosphenes feature relatively large polarization of the P–P bond, which is more akin to E-10*, with the exception of the ammonium cation, E-17*.

Natural Localized Molecular Orbital (NLMO) analysis of E-8* reveals the presence of a P–P π NLMO and a P–P π* NLMO, which closely resemble the nodal structure calculated for the HOMO and LUMO, respectively (Fig. 6D and E). The NLMO analysis further identified a P–Cl σ* NLMO which resembles the LUMO+2 and a filled Cl-centered 3p orbital, which appears prominently in both the HOMO and LUMO (Fig. 6F and G).

Intriguingly, second-order perturbation theory analysis of E-8*, E-9*, and E-10* reveals delocalization from an X-centered (X = Cl, Br, I) lone pair to the P–P π* orbital to afford an energy of stabilization of 9.39, 7.82, and 6.30 kcal mol−1, respectively (Fig. 6H). Furthermore, delocalization of electron density from the P–C σ orbital and the lone pair of the C-bound P atom to the terminal P–X σ* orbital (X = Cl, Br, I) afford a total energy of stabilization of 4.73, 4.92, and 4.53 kcal mol−1 for E-8*, E-9*, and E-10*, respectively (Fig. 6I). In order to more broadly assess the relative strengths of the non-covalent donor–acceptor interactions present in E-8*, E-9*, and E-10*, we performed deletion calculations, in which all non-covalent interactions from the halide to the {P2} unit and vice versa were deleted. The removal of these non-covalent interactions resulted in the destabilization of E-8*, E-9*, and E-10* by 30.73, 25.73, and 19.96 kcal mol−1, respectively. The results of these deletion calculations are in line with the general trend that non-covalent interactions between the halide and the {P2} unit become less efficient from E-8* > E-9* > E-10*.

Natural Resonance Theory (NRT) analysis identified leading resonance structures featuring a P–P double bond and a polar, covalent P–X (X = Cl, Br, I) single bond for the simple theoretical molecules E-MePPCl, E-MePPBr, and E-MePPI, respectively (SI Tables S18–S20). The NRT analysis is consistent with increasing ionicity of the P–X bond from E-MePPI < E-MePPBr < E-MePPCl.

Conclusions

In conclusion, we report the isolation of 8·(Et2O)2, a thermally robust, monomeric arylhalodiphospene. Compound 8 features a terminal {PPCl} unit and can thus be regarded as a ‘masked’ aryldiphosphadiazonium chloride, marking a significant advancement in the context of decades of diphosphene chemistry. The P–P bond of 8 could be cleaved via protonolysis by aqueous hydrobromic acid, and the synthetic utility of the P–Cl bond in 8 was demonstrated in halogen-exchange reactions with TMSBr and TMSI to form the monomeric arylhalodiphosphenes, 9 and 10, respectively. Treatment of 8 with GaCl3 or AlCl3 resulted in rapid decomposition to form complex reaction mixtures. However, 8 participates in coordination chemistry that is typical of diphosphenes; treatment of 8 with AgCF3SO3 forms, 11. In 8, 9, 10, and 11, SC-XRD experiments clearly identified the presence of both the E and the Z isomer with respect to the diphosphene motif in solid state. Our theoretical investigation elucidated trends in bonding amongst the theoretical arylhalodiphosphenes E-8*, E-9*, and E-10*. Notably, the HOMO increases in energy, the LUMO and LUMO+1 decrease in energy, and the P–X (X = Cl, Br, I) bond weakens as the terminal halide increases in size. Further investigations into the reactivity of monomeric arylhalodiphosphenes are currently underway, as are efforts to isolate a genuine diphosphadiazonium salt.

Author contributions

J. S. W.: conceptualization, data curation, funding acquisition, investigation (chemical synthesis, data acquisition, X-ray crystallography, DFT methods), methodology, visualization, writing – original draft, writing – review and editing. N. G.: investigation (chemical synthesis). W. J. R.: investigation (chemical synthesis). A. E. C.: investigation (X-ray crystallography). B. v. I.: investigation (acquisition of VT-NMR data). M. M.: conceptualization, funding acquisition, project administration, resources, supervision, writing – review and editing.

Conflicts of interest

There are no conflicts to declare.

Data availability

CCDC 2501235–2501241, 2512823, 2512824, and 2523752 contain the supplementary crystallographic data for this paper.75a–j

The data supporting this article have been included as part of the supplementary information (SI). Supplementary information is available. See DOI: https://doi.org/10.1039/d6sc00723f.

Acknowledgements

We thank the University of Oxford and UKRI for funding (EP/Y037391/1) and supporting M. M. We also thank the ERC for funding a Marie Skłodowska-Curie Fellowship (101205172) and supporting J. S. W. We are also grateful to the University of Oxford for computing resources.

Notes and references

  1. R. C. Fischer and P. P. Power, Chem. Rev., 2010, 110(7), 3877–3923 CrossRef CAS PubMed.
  2. D. You and F. P. Gabbaï, Trends Chem., 2019, 1(5), 485–496 CrossRef CAS.
  3. L. Zhao, S. Pan, N. Holzmann, P. Schwerdtfeger and G. Frenking, Chem. Rev., 2019, 119(14), 8781–8845 CrossRef CAS PubMed.
  4. R. West, Angew. Chem., Int. Ed., 1987, 26(12), 1201–1211 CrossRef.
  5. L. E. Gusel'nikov and N. S. Nametkin, Chem. Rev., 1979, 79(6), 529–577 CrossRef.
  6. V. J. Eilrich and E. Hey-Hawkins, Coord. Chem. Rev., 2021, 437, 213749 CrossRef CAS.
  7. V. Nesterov, D. Reiter, P. Bag, P. Frisch, R. Holzner, A. Porzelt and S. Inoue, Chem. Rev., 2018, 118(19), 9678–9842 CrossRef CAS PubMed.
  8. E. Rivard and P. P. Power, Inorg. Chem., 2007, 46(24), 10047–10064 CrossRef CAS PubMed.
  9. J. S. Wenger and T. C. Johnstone, Dalton Trans., 2024, 53(20), 8524–8534 Search PubMed.
  10. P. Griefs, Adv. Cycloaddit., 1858, 106(1), 123–125 Search PubMed.
  11. T. Sandmeyer, Ber. Dtsch. Chem. Ges., 1884, 17(2), 2650–2653 Search PubMed.
  12. R. Pschorr, Ber. Dtsch. Chem. Ges., 1896, 29(1), 496–501 CrossRef CAS.
  13. M. Gomberg and W. E. Bachmann, J. Am. Chem. Soc., 1924, 46(10), 2339–2343 CrossRef CAS.
  14. G. Balz and G. Schiemann, Ber. Dtsch. Chem. Ges., 1927, 60(5), 1186–1190 CrossRef.
  15. H. Meerwein, E. Büchner and K. van Emster, J. Prakt. Chem., 1939, 152(7–10), 237–266 CrossRef CAS.
  16. F. Mo, D. Qiu, L. Zhang and J. Wang, Chem. Rev., 2021, 121(10), 5741–5829 CrossRef CAS PubMed.
  17. E. Niecke, M. Nieger and F. Reichert, Angew. Chem., Int. Ed., 1988, 27(12), 1715–1716 CrossRef.
  18. C. Rømming, P. Karvonen, A. Holm, P. H. Nielsen and J. Munch-Petersen, Acta Chem. Scand., 1963, 17(5), 1444–1454 CrossRef.
  19. E. Niecke, R. Detsch, M. Nieger, F. Reichert and W. Schoeller, Bull. Soc. Chim. Fr., 1993, 130(1), 25–31 CAS.
  20. A. Villinger, P. Mayer and A. Schulz, Chem. Commun., 2006,(11), 1236–1238 RSC.
  21. C. Hu, N. H. Rees, M. Pink and J. M. Goicoechea, Nat. Chem., 2024, 16(11), 1855–1860 CrossRef CAS PubMed.
  22. X. Wang, Y. Chen, X. Li, L. Xu and G. Tan, J. Am. Chem. Soc., 2025, 147(41), 36980–36986 CrossRef CAS PubMed.
  23. M. Yoshifuji, I. Shima, N. Inamoto, K. Hirotsu and T. Higuchi, J. Am. Chem. Soc., 1981, 103(15), 4587–4589 CrossRef CAS.
  24. D. J. Liptrot and P. P. Power, Nat. Rev. Chem., 2017, 1(0004), 1–12 Search PubMed.
  25. O. Back, B. Donnadieu, P. Parameswaran, G. Frenking and G. Bertrand, Nat. Chem., 2010, 2(5), 369–373 Search PubMed.
  26. J. Sun, H. Verplancke, J. I. Schweizer, M. Diefenbach, C. Würtele, M. Otte, I. Tkach, C. Herwig, C. Limberg, S. Demeshko, M. C. Holthausen and S. Schneider, Chem, 2021, 7(7), 1952–1962 CAS.
  27. S. Wang, J. D. Sears, C. E. Moore, A. L. Rheingold, M. L. Neidig and J. S. Figueroa, Science, 2022, 375(6587), 1393–1397 Search PubMed.
  28. Y. Wang, Y. Xie, P. Wei, R. B. King, H. F. Schaefer, P. v. R. Schleyer and G. H. Robinson, J. Am. Chem. Soc., 2008, 130(45), 14970–14971 CrossRef CAS PubMed.
  29. J. Du, D. Hunger, J. A. Seed, J. D. Cryer, D. M. King, A. J. Wooles, J. van Slageren and S. T. Liddle, J. Am. Chem. Soc., 2021, 143(14), 5343–5348 Search PubMed.
  30. V. D. Romanenko, Curr. Org. Chem., 2025, 30, 1–11 Search PubMed.
  31. M. Yoshifuji, Eur. J. Inorg. Chem., 2016, 2016(5), 607–615 CrossRef CAS.
  32. D.-L. An, K. Toyota, M. Yasunami and M. Yoshifuji, J. Organomet. Chem., 1996, 508(1–2), 7–12 CrossRef CAS.
  33. C. Couret, J. Escudié and J. Satgé, Tetrahedron Lett., 1982, 23(47), 4941–4942 CrossRef CAS.
  34. F. Rivière, S. Ito and M. Yoshifuji, Tetrahedron Lett., 2002, 43(1), 119–121 CrossRef.
  35. D. Romanenko, V. L. Rudzevich, E. B. Rusanov, A. N. Chernega, A. Senio, J.-M. Sotiropoulos, G. Pfister-Guillouzo and M. Sanchez, J. Chem. Soc., Chem. Commun., 1995, 13, 1383–1385 RSC.
  36. J. Bresien, C. Hering, A. Schulz and A. Villinger, Chem.–Eur. J., 2014, 20(39), 12607–12615 CrossRef CAS PubMed.
  37. L. N. Markovskii, V. D. Romanenko, M. I. Povolotskii, A. V. Ruban and E. O. Klebanskii, Zh. Obshch. Khim., 1986, 56(9), 2157–2158 CAS.
  38. L. N. Markovski, V. D. Romanenko and A. V. Ruban, Phosphorus, Sulfur Relat. Elem., 1987, 30(1–2), 447–450 CrossRef.
  39. A. V. Ruban and L. S. Kachkovskaya, Phosphorus, Sulfur Silicon Relat. Elem., 1990, 51(1–4), 334 CrossRef.
  40. J. Bresien, K. Faust, A. Schulz and A. Villinger, Angew. Chem., Int. Ed., 2015, 54(23), 6926–6930 CrossRef CAS PubMed.
  41. J. Bresien, A. Schulz and A. Villinger, Phosphorus, Sulfur Silicon Relat. Elem., 2016, 191(4), 601–604 CrossRef CAS.
  42. M. Wu, H. Li, W. Chen, D. Wang, Y. He, L. Xu, S. Ye and G. Tan, Chem, 2023, 9(9), 2573–2584 CAS.
  43. T. Matsuo, K. Suzuki, T. Fukawa, B. Li, M. Ito, Y. Shoji, T. Otani, L. Li, M. Kobayashi, M. Hachiya, Y. Tahara, D. Hashizume, T. Fukunaga, A. Fukazawa, Y. Li, H. Tsuji and K. Tamao, Bull. Chem. Soc. Jpn., 2011, 84(11), 1178–1191 CrossRef CAS.
  44. M. Olaru, S. Mebs and J. Beckmann, Angew. Chem., Int. Ed., 2021, 60(35), 19133–19138 CrossRef CAS PubMed.
  45. Y. He, C. Dai, D. Wang, J. Zhu and G. Tan, J. Am. Chem. Soc., 2022, 144(11), 5126–5135 CrossRef CAS PubMed.
  46. M. Janssen, S. Mebs and J. Beckmann, Chem. Commun., 2023, 59(47), 7267–7270 RSC.
  47. M. Wu, W. Chen, D. Wang, Y. Chen, S. Ye and G. Tan, Natl. Sci. Rev., 2023, nwad169 CrossRef CAS PubMed.
  48. M. Janssen, S. Mebs and J. Beckmann, ChemPlusChem, 2023, 88(3), e202200429 Search PubMed.
  49. Y. Chen, M. Wu, D. Wang, N. Yuan, L. Xu and G. Tan, Organometallics, 2023, 42(7), 538–542 CrossRef CAS.
  50. D. Wang, H. Chen, Y. He, X. Chen, L. Zhang and G. Tan, Chin. J. Chem., 2023, 42(7), 736–742 CrossRef.
  51. D. Wang, W. Chen, C. Zhai, L. Zhao, S. Ye and G. Tan, J. Am. Chem. Soc., 2023, 145(12), 6914–6920 CrossRef CAS PubMed.
  52. D. Wang, C. Zhai, Y. Chen, Y. He, X.-D. Chen, S. Wang, L. Zhao, G. Frenking, X. Wang and G. Tan, Nat. Chem., 2023, 15(2), 200–205 CrossRef CAS PubMed.
  53. Y. Pang, N. Nöthling, M. Leutzsch, L. Kang, E. Bill, M. van Gastel, E. Reijerse, R. Goddard, L. Wagner, D. SantaLucia, S. DeBeer, F. Neese and J. Cornella, Science, 2023, 380(6649), 1043–1048 CrossRef CAS PubMed.
  54. H. Chen, W. Chen, D. Wang, Y. Chen, Z. Liu, S. Ye, G. Tan and S. Gao, Angew. Chem., Int. Ed., 2024, 63(20), e202402093 CrossRef CAS PubMed.
  55. M. Janssen, T. Frederichs, M. Olaru, E. Lork, E. Hupf and J. Beckmann, Science, 2024, 385(6706), 318–321 CrossRef CAS PubMed.
  56. Y. Chen, P. Su, D. Wang, Z. Ke and G. Tan, Nat. Commun., 2024, 15(4579), 1–9 Search PubMed.
  57. X. Li, Y. Zhang, Z. Wang, Z. He, L. Xu and G. Tan, Organometallics, 2025, 44(22), 2620–2624 Search PubMed.
  58. Z. Wang, C. Ding, Y. Chen, M. Huang, D. Wang, L. Xu, S. Pan, S. Ye and G. Tan, Nat. Chem., 2026, 18(2), 356–363 Search PubMed.
  59. G. Tan and S. Ye, Acc. Chem. Res., 2025, 59(3), 397–410 Search PubMed.
  60. M. Brynda, Coord. Chem. Rev., 2005, 249(19–20), 2013–2034 CrossRef CAS.
  61. J. T. Fleming and L. J. Higham, Coord. Chem. Rev., 2015, 297–298, 127–145 Search PubMed.
  62. A. A. Nasrullah, M. Fischer, F. Dankert, E. Barath and C. Hering-Junghans, Organometallics, 2025, 44(7), 788–791 Search PubMed.
  63. L. Liu, D. A. Ruiz, D. Munz and G. Bertrand, Chem, 2016, 1(1), 147–153 CAS.
  64. A. H. Cowley, J. E. Kilduff, T. H. Newman and M. Pakulski, J. Am. Chem. Soc., 1982, 104(21), 5820–5821 CrossRef CAS.
  65. P. Jutzi, U. Meyer, B. Krebs and M. Dartmann, Angew. Chem., 1986, 98(10), 894–895 Search PubMed.
  66. R. C. Smith, E. Urnezius, K.-C. Lam, A. L. Rheingold and J. D. Protasiewicz, Inorg. Chem., 2002, 41(20), 5296–5299 CrossRef CAS PubMed.
  67. A.-M. Caminade, M. Verrier, C. Ades, N. Paillous and M. Koenig, J. Chem. Soc., Chem. Commun., 1984,(13), 875–877 RSC.
  68. R. Deka, M. Temel, S. Crespi and A. Orthaber, Dalton Trans., 2025, 54(38), 14241–14253 RSC.
  69. A. Hinz, A. Schulz and A. Villinger, Angew. Chem., Int. Ed., 2015, 54(9), 2776–2779 CrossRef CAS PubMed.
  70. E. Niecke, O. Altmeyer and M. Nieger, Angew. Chem., Int. Ed., 1991, 30(9), 1136–1138 CrossRef.
  71. A. H. Cowley, N. C. Norman and M. Pakulski, J. Chem. Soc., Chem. Commun., 1984, 16, 1054–1055 RSC.
  72. X. Pan, L. Zhang, Y. Zhao, G. Tan, H. Ruan and X. Wang, Chin. J. Chem., 2020, 38(4), 351–355 CrossRef CAS.
  73. R. F. W. Bader, Chem. Rev., 1991, 91, 893–928 CrossRef CAS.
  74. B. Lindquist-Kleissler, J. S. Wenger and T. C. Johnstone, Inorg. Chem., 2021, 60(3), 1846–1856 Search PubMed.
  75. (a) CCDC 2501235: Experimental Crystal Structure Determination, 2026,  DOI:10.5517/ccdc.csd.cc2pyr0f; (b) CCDC 2501236: Experimental Crystal Structure Determination, 2026,  DOI:10.5517/ccdc.csd.cc2pyr1g; (c) CCDC 2501237: Experimental Crystal Structure Determination, 2026,  DOI:10.5517/ccdc.csd.cc2pyr2h; (d) CCDC 2501238: Experimental Crystal Structure Determination, 2026,  DOI:10.5517/ccdc.csd.cc2pyr3j; (e) CCDC 2501239: Experimental Crystal Structure Determination, 2026,  DOI:10.5517/ccdc.csd.cc2pyr4k; (f) CCDC 2501240: Experimental Crystal Structure Determination, 2026,  DOI:10.5517/ccdc.csd.cc2pyr5l; (g) CCDC 2501241: Experimental Crystal Structure Determination, 2026,  DOI:10.5517/ccdc.csd.cc2pyr6m; (h) CCDC 2512823: Experimental Crystal Structure Determination, 2026,  DOI:10.5517/ccdc.csd.cc2qbstp; (i) CCDC 2512824: Experimental Crystal Structure Determination, 2026,  DOI:10.5517/ccdc.csd.cc2qbsvq; (j) CCDC 2523752: Experimental Crystal Structure Determination, 2026,  DOI:10.5517/ccdc.csd.cc2qq5c0.

This journal is © The Royal Society of Chemistry 2026
Click here to see how this site uses Cookies. View our privacy policy here.